India’s leading drug maker, Aurobindo Pharma has got sanction from the US Food and Drug Administration (USFDA) for Ceftriaxone injection.

Ceftriaxone is a yellowish-orange crystalline powder belongs to group of antibiotics named cephalosporins, which is used as injection in the treatment of severe infections.

It is available in five strengths i.e. 250 mg, 500 mg, 1g, 2g and 10g.

Shares of the company closed up Rs 7.55, or 2.71%, at Rs 286.4. The total volume of shares traded at the BSE was 39,689.